MPN Congress 2023

Patrick DalyMyeloproliferative Neoplasms | November 7, 2023
Primary myelofibrosis developed secondary neoplasms earlier and at higher rates versus other myeloproliferative neoplasms.
Patrick DalyMyeloproliferative Neoplasms | November 7, 2023
Essential thrombocythemia with CALR mutations had a higher risk of progression to myelofibrosis compared with JAK2 mutations.
Patrick DalyMyeloproliferative Neoplasms | November 7, 2023
A deep learning-based pathomics approach had potential in estimating bone marrow cellularity in patients with MPNs.
Advertisement
Patrick DalyMyeloproliferative Neoplasms | November 7, 2023
MPNs were not the primary cause of strokes in veterans, though researchers found they were strongly associated.
Patrick DalyMyeloproliferative Neoplasms | November 7, 2023
Patients with polycythemia vera developed secondary malignancies at a higher rate versus other myeloproliferative neoplasms.
Advertisement
Advertisement
Advertisement